To UM home page

Researcher

Boersma, L.J.

Endowed chair - Professor of practice

View graph of relations
1 - 50 out of 64Page size: 50
  1. 2019
  2. Published
    Jacobs, M., Boersma, L. J., Swart, R., Mannens, R., Reymen, B., Korver, F., ... Dekker, A. (2019). Electronic Health Record implementation in a large academic radiotherapy department: Temporarily disruptions but long-term benefits. International Journal of Medical Informatics, 129, 342-348. https://doi.org/10.1016/j.ijmedinf.2019.07.008
  3. Published
    Savelberg, W., Boersma, L. J., Smidt, M., Goossens, M. F. J., Hermanns, R., & van der Weijden, T. (2019). Does lack of deeper understanding of shared decision making explains the suboptimal performance on crucial parts of it? An example from breast cancer care. European Journal of Oncology Nursing, 38, 92-97. https://doi.org/10.1016/j.ejon.2018.12.004
  4. 2018
  5. Published
    Mollen, E. W. J., Ient, J., Tjan-Heijnen, V. C. G., Boersma, L. J., Miele, L., Smidt, M. L., & Vooijs, M. A. G. G. (2018). Moving Breast Cancer Therapy up a Notch. Frontiers in Oncology, 8, [518]. https://doi.org/10.3389/fonc.2018.00518
  6. Published
    Klaassen, L. A., Dirksen, C. D., Boersma, L. J., Hoving, C., & B-Beslist-Grp (2018). A novel patient decision aid for aftercare in breast cancer patients: A promising tool to reduce costs by individualizing aftercare. Breast, 41, 144-150. https://doi.org/10.1016/j.breast.2018.06.015
  7. Published
    Young Boost Trial Res Grp, Brouwers, P. J. A. M., van Werkhoven, E., Bartelink, H., Fourquet, A., Lemanski, C., ... Boersma, L. J. (2018). Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial. Radiotherapy and Oncology, 128(3), 434-441. https://doi.org/10.1016/j.radonc.2018.06.020
  8. Published
    Langendijk, J. A., Boersma, L. J., Rasch, C. R. N., van Vulpen, M., Reitsma, J. B., van der Schaaf, A., & Schuit, E. (2018). Clinical Trial Strategies to Compare Protons With Photons. Seminars in Radiation Oncology, 28(2), 79-87. https://doi.org/10.1016/j.semradonc.2017.11.008
  9. Published
    Kalter, J., Verdonck-de Leeuw, I. M., Sweegers, M. G., Aaronson, N. K., Jacobsen, P. B., Newton, R. U., ... Buffart, L. M. (2018). Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs. Psycho-Oncology, 27(4), 1150-1161. https://doi.org/10.1002/pon.4648
  10. Published
    Klaassen, L., Dirksen, C., Boersma, L., Hoving, C., & B-Beslist-Grp (2018). Developing an aftercare decision aid: assessing health professionals' and patients' preferences. European Journal of Cancer Care, 27(2), [e12730]. https://doi.org/10.1111/ecc.12730
  11. Published
    Brouwers, P. J. A. M., van Loon, J., Houben, R. M. A., Paulissen, J., Engelen, S. M. E., Heuts, M., ... Boersma, L. J. (2018). Are PROMs sufficient to record late outcome of breast cancer patients treated with radiotherapy? A comparison between patient and clinician reported outcome through an outpatient clinic after 10 years of follow up. Radiotherapy and Oncology, 126(1), 163-169. https://doi.org/10.1016/j.radonc.2017.08.004
  12. Published
    Jacobs, M., Boersma, L., & van Merode, F. (2018). Implementatie van innovaties in de zorg: Radiotherapie als voorbeeld. Ned Tijdschr Geneeskd, 162, 1-4. [D2538].
  13. Published
    Boersma, L., van Vulpen, M., Rasch, C. R. N., & Langendijk, J. A. (2018). Protonencentra: ze zijn er, wat nu? Ned Tijdschr Geneeskd, 162, 1-6. [D2250].
  14. 2017
  15. Published
    Zegers, C. M. L., Baeza, J. A., van Elmpt, W., Murrer, L. H. P., Verhoeven, K., Boersma, L., ... Nijsten, S. M. J. J. G. (2017). Three-dimensional dose evaluation in breast cancer patients to define decision criteria for adaptive radiotherapy. Acta Oncologica, 56(11), 1487-1494. https://doi.org/10.1080/0284186X.2017.1349334
  16. Published
    Lightowlers, S. V., Boersma, L. J., Fourquet, A., Kirova, Y. M., Offersen, B. V., Poortmans, P., ... Coles, C. E. (2017). Preoperative breast radiation therapy: Indications and perspectives. European Journal of Cancer, 82, 184-192. https://doi.org/10.1016/j.ejca.2017.06.014
  17. Published
    Savelberg, W., van der Weijden, T., Boersma, L., Smidt, M., Willekens, C., & Moser, A. (2017). Developing a patient decision aid for the treatment of women with early stage breast cancer: the struggle between simplicity and complexity. BMC Medical Informatics and Decision Making, 17, [112]. https://doi.org/10.1186/s12911-017-0505-6
  18. Published
    Vriens, I. J. H., Keymeulen, K., Lobbes, M. B. I., van Bommel, A. C. M., Nieuwenhuijzen, G. A. P., Smidt, M. L., ... Natl Breast Canc Org Netherlands (2017). Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers. European Journal of Cancer, 81, 74-80. https://doi.org/10.1016/j.ejca.2017.05.012
  19. Published
    van Haaren, P., Claassen-Janssen, F., van de Sande, I., Boersma, L., van der Sangen, M., & Hurkmans, C. (2017). Heart position variability during voluntary moderate deep inspiration breath-hold radiotherapy for breast cancer determined by repeat CBCT scans. Physica Medica: European journal of medical physics, 40, 88-94. https://doi.org/10.1016/j.ejmp.2017.07.014
  20. Published
    van Roozendaal, L. M., Vane, M. L. G., van Dalen, T., van der Hage, J. A., Strobbe, L. J. A., Boersma, L. J., ... Smidt, M. L. (2017). Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08). BMC Cancer, 17, [459]. https://doi.org/10.1186/s12885-017-3443-x
  21. Published
    Lobbes, M. B. I., Vriens, I. J. H., van Bommel, A. C. M., Nieuwenhuijzen, G. A. P., Smidt, M. L., Boersma, L. J., ... Tjan-Heijnen, V. C. G. (2017). Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers. Breast Cancer Research and Treatment, 162(2), 353-364. https://doi.org/10.1007/s10549-017-4117-8
  22. Published
    Lambin, P., Zindler, J., Vanneste, B. G. L., Van De Voorde, L., Eekers, D., Compter, I., ... Walsh, S. (2017). Decision support systems for personalized and participative radiation oncology. Advanced Drug Delivery Reviews, 109, 131-153. https://doi.org/10.1016/j.addr.2016.01.006
  23. Published
    van der Salm, A., Murrer, L., Steenbakkers, I., Houben, R., & Boersma, L. J. (2017). Actual target coverage after setup verification using surgical clips compared with external skin markers in postoperative breast cancer radiation therapy. Practical radiation oncology, 7(6), E369-E376. https://doi.org/10.1016/j.prro.2017.04.012
  24. Published
    Jacobs, M., Boersma, L., Dekker, A., Swart, R., Lambin, P., de Ruysscher, D., ... van Merode, F. (2017). What is the impact of innovation on output in healthcare with a special focus on treatment innovations in radiotherapy? A literature review. British Journal of Radiology, 90(1079), [20170251]. https://doi.org/10.1259/bjr.20170251
  25. 2016
  26. Published
    Aalders, K. C., van Bommel, A. C. M., van Dalen, T., Sonke, G. S., van Diest, P. J., Boersma, L. J., & van der Heiden-van der Loo, M. (2016). Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer. European Journal of Cancer, 63, 118-126. https://doi.org/10.1016/j.ejca.2016.05.010
  27. Published
    Brouwers, P. J. A. M., van Werkhoven, E., Bartelink, H., Fourquet, A., Lemanski, C., van Loon, J., ... Boersma, L. J. (2016). Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial. Radiotherapy and Oncology, 120(1), 107-113. https://doi.org/10.1016/j.radonc.2016.04.017
  28. Published
    Aalders, K. C., Postma, E. L., Strobbe, L. J., van der Heiden-van der Loo, M., Sonke, G. S., Boersma, L. J., ... van Dalen, T. (2016). Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer. Journal of Clinical Oncology, 34(18), 2107-2116. https://doi.org/10.1200/JCO.2015.64.3536
  29. Published
    Aalders, K. C., Postma, E. L., Strobbe, L. J., van der Heiden-van der Loo, M., Sonke, G. S., Boersma, L. J., ... van Dalen, T. (2016). Contemporary local and regional recurrence rates in very young breast cancer patients. Cancer Research, 76, [P5-08-01]. https://doi.org/10.1158/1538-7445.SABCS15-P5-08-01
  30. Published
    Aalders, K. C., Sonke, G. S., van der Heiden-van der Loo, M., Boersma, L. J., van Diest, P. J., Siesling, S., & van Dalen, T. (2016). Contemporary risk of local breast cancer recurrence after neo-adjuvant chemotherapy: Results of a population-based cohort study. Cancer Research, 76(4 supp.), [P5-08-36]. https://doi.org/10.1158/1538-7445.SABCS15-P5-08-36
  31. Published
    Offersen, B. V., Boersma, L. J., Kirkove, C., Hol, S., Aznar, M. C., Biete Sola, A., ... Poortmans, P. (2016). ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiotherapy and Oncology, 118(1), 205-208. https://doi.org/10.1016/j.radonc.2015.12.027
  32. Published
    Jacobs, M., Boersma, L., Merode, F. V., Dekker, A., Verhaegen, F., Linden, L., & Lambin, P. (2016). How efficient is translational research in radiation oncology? The example of a large Dutch academic radiation oncology department. British Journal of Radiology, 89(1064), [20160129]. https://doi.org/10.1259/bjr.20160129
  33. Published
    Jacobs, M., Boersma, L., Dekker, A., Bosmans, G., van Merode, F., Verhaegen, F., ... Lambin, P. (2016). What is the degree of innovation routinely implemented in Dutch radiotherapy centres? A multicentre cross-sectional study. British Journal of Radiology, 89, [20160601]. https://doi.org/10.1259/bjr.20160601
  34. 2015
  35. Published
    van Roozendaal, L. M., Schipper, R-J., Smit, L. H. M., Brans, B. T., Beets-Tan, R. G. H., Lobbes, M. B. I., ... Smidt, M. L. (2015). Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer. Annals of Surgical Oncology, 22(12), 3824-3830. https://doi.org/10.1245/s10434-015-4413-7
  36. Published
    Lambin, P., Zindler, J., Vanneste, B., Van De Voorde, L., Jacobs, M., Eekers, D., ... Walsh, S. (2015). Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine. Acta Oncologica, 54(9), 1289-1300. https://doi.org/10.3109/0284186X.2015.1062136
  37. Published
    Boersma, L. J. (2015). Kwaliteit in borstkankerzorg: O.K. & T.O.F. ?! Maastricht: Maastricht University. https://doi.org/10.26481/spe.20151002lb
  38. Published
    van Roozendaal, L. M., de Wilt, J. H. W., van Dalen, T., van der Hage, J. A., Strobbe, L. J. A., Boersma, L. J., ... Smidt, M. L. (2015). The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07). BMC Cancer, 15, [610]. https://doi.org/10.1186/s12885-015-1613-2
  39. Published
    Meattini, I., Boersma, L., Livi, L., Kirkove, C., Gabrys, D., Somaiah, N., ... Rivera, S. (2015). Letters Regarding the TARGIT-A Trial: The Editor's Introduction. International Journal of Radiation Oncology Biology Physics, 92(5), 960-961. https://doi.org/10.1016/j.ijrobp.2015.05.030
  40. Published
    Brouwers, P. J. A. M., Lustberg, T., Borger, J. H., van Baardwijk, A. A. W., Jager, J. J., Murrer, L. H. P., ... Boersma, L. J. (2015). Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy. In Practical Radiation Oncology (pp. e135-e141). (Practical Radiation Oncology; Vol. 5). Elsevier Inc.. https://doi.org/10.1016/j.prro.2014.10.005
  41. Published
    Jacobs, M., Boersma, L., Dekker, A., Govers, M., Lambin, P., & van Merode, F. (2015). How to measure innovation in radiotherapy: an application of the Delphi method. Journal of Hospital Administration, 4(4), 14-23. https://doi.org/10.5430/jha.v4n4p14
  42. Published
    Jacobs, M., Boersma, L., Dekker, A., Hermanns, E., Houben, R., Govers, M., ... Lambin, P. (2015). Organizational development trajectory of a large academic radiotherapy department set up similarly to a prospective clinical trial: the MAASTRO experience. British Journal of Radiology, 88(1049), [20140559]. https://doi.org/10.1259/bjr.20140559
  43. Published
    Savelberg, W., Moser, A., Smidt, M., Boersma, L., Haeckens, C., & van der Weijden, T. (2015). Protocol for a pre-implementation and post-implementation study on shared decision-making in the surgical treatment of women with early-stage breast cancer. BMJ Open, 5(3), [e007698]. https://doi.org/10.1136/bmjopen-2015-007698
  44. Published
    Offersen, B. V., Boersma, L. J., Kirkove, C., Hol, S., Aznar, M. C., Biete Sola, A., ... Poortmans, P. (2015). ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiotherapy and Oncology, 114(1), 3-10. https://doi.org/10.1016/j.radonc.2014.11.030
  45. 2014
  46. Published
    Berbers, J., van Baardwijk, A., Houben, R., Heuts, E., Smidt, M., Keymeulen, K., ... Boersma, L. J. (2014). 'Reconstruction: Before or after postmastectomy radiotherapy?' A systematic review of the literature. European Journal of Cancer, 50(16), 2752-2762. https://doi.org/10.1016/j.ejca.2014.07.023
  47. Published
    Oberije, C., Nalbantov, G., Dekker, A., Boersma, L., Borger, J., Reymen, B., ... Lambin, P. (2014). A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: A step toward individualized care and shared decision making. Radiotherapy and Oncology, 112(1), 37-43. https://doi.org/10.1016/j.radonc.2014.04.012
  48. Published
    van der Leij, F., Elkhuizen, P. H. M., Janssen, T. M., Poortmans, P., van der Sangen, M., Scholten, A. N., ... Boersma, L. J. (2014). Target volume delineation in external beam partial breast irradiation: Less inter-observer variation with preoperative- compared to postoperative delineation. Radiotherapy and Oncology, 110(3), 467-470. https://doi.org/10.1016/j.radonc.2013.10.033
  49. 2013
  50. Published
    Lambin, P., Roelofs, E., Reymen, B., Velazquez, E. R., Buijsen, J., Zegers, C. M. L., ... Dekker, A. (2013). 'Rapid Learning health care in oncology' - An approach towards decision support systems enabling customised radiotherapy. Radiotherapy and Oncology, 109(1), 159-164. https://doi.org/10.1016/j.radonc.2013.07.007
  51. 2012
  52. Published
    Scharf, C., Ng, G. A., Wieczorek, M., Deneke, T., Furniss, S. S., Murray, S., ... Boersma, L. V. A. (2012). European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. EP Europace, 14(12), 1700-1707. https://doi.org/10.1093/europace/eus188
  53. Published
    Boersma, L. J., Janssen, T., Elkhuizen, P. H. M., Poortmans, P., van der Sangen, M., Scholten, A. N., ... van Vliet, C. (2012). Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines. Radiotherapy and Oncology, 103(2), 178-182. https://doi.org/10.1016/j.radonc.2011.12.021
  54. Published
    Khanfir, K., Kallel, A., Villette, S., Belkacemi, Y., Vautravers, C., TanDat Nguyen, ... Sozzi, W. J. (2012). MANAGEMENT OF ADENOID CYSTIC CARCINOMA OF THE BREAST: A RARE CANCER NETWORK STUDY. International Journal of Radiation Oncology Biology Physics, 82(5), 2118-2124. https://doi.org/10.1016/j.ijrobp.2010.12.008
  55. Published
    Peulen, H., Hanbeukers, B., Boersma, L., van Baardwijk, A., van den Ende, P., Houben, R., ... Borger, J. (2012). FORWARD INTENSITY-MODULATED RADIOTHERAPY PLANNING IN BREAST CANCER TO IMPROVE DOSE HOMOGENEITY: FEASIBILITY OF CLASS SOLUTIONS. International Journal of Radiation Oncology Biology Physics, 82(1), 394-400. https://doi.org/10.1016/j.ijrobp.2010.09.005
  56. Published
    van Loon, J., Siedschlag, C., Stroom, J., Blauwgeers, H., van Suylen, R-J., Knegjens, J., ... Gilhuijs, K. (2012). MICROSCOPIC DISEASE EXTENSION IN THREE DIMENSIONS FOR NON-SMALL-CELL LUNG CANCER: DEVELOPMENT OF A PREDICTION MODEL USING PATHOLOGY-VALIDATED POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY FEATURES. International Journal of Radiation Oncology Biology Physics, 82(1), 448-456. https://doi.org/10.1016/j.ijrobp.2010.09.001
  57. Published
    Benning, T. M., Kimman, M. L., Dirksen, C. D., Boersma, L. J., & Dellaert, B. G. C. (2012). Combining Individual-Level Discrete Choice Experiment Estimates and Costs to Inform Health Care Management Decisions about Customized Care: The Case of Follow-Up Strategies after Breast Cancer Treatment. Value in Health, 15(5), 680-689. https://doi.org/10.1016/j.jval.2012.04.007
  58. 2011
  59. Published
    Siedschlag, C., Boersma, L., van Loon, J., Rossi, M., van Baardwijk, A., Gilhuijs, K., & Stroom, J. (2011). The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer. Radiotherapy and Oncology, 100(3), 344-350. https://doi.org/10.1016/j.radonc.2011.08.046
Previous 1 2 Next

UM personal profile

UM postal address
P.O. Box 616
6200 MD Maastricht
The Netherlands

UM visiting address
Minderbroedersberg 4-6
6211 LK Maastricht
The Netherlands
Phone: +31 43 388 2222

Quick Links